参考文献/References:
[1] Naito Y,Masuyama T,Ishihara M.Iron and cardiovascular diseases[J].J Cardiol,2021,77(2):160-165.
[2] Flora GD,Nayak MK.A brief review of cardiovascular diseases,associatedrisk factors and current treatment regimes[J].Curr Pharm Des,2019,25(38):4063-4084.
[3] 陈伟国,朱萧玲,常 盼,等.芪参益气滴丸对急性心肌梗死PCI术后患者血清学指标及预后的影响[J].陕西中医,2020,41(1):20-23.
[4] 吕 涛.丹红注射液对急性心肌梗死心肌再灌注损伤保护作用的相关研究[J].辽宁中医杂志,2020,47(8):118-120.
[5] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会,《中国循环杂志》编辑委员会.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725.
[6] 田德禄,蔡 淦.中医内科学[M].上海:上海科学技术出版社,2006:125-132.
[7] 张嘉宁,张海柱,罗进光.瑞替普酶联合还原型谷胱甘肽治疗急性ST段拾高型心肌梗死的临床价值[J].中华老年医学杂志,2014,33(2):143-146.
[8] 郑丽莉.芎归六君子汤对心肌梗死模型大鼠微血管新生和MMP、TIMP蛋白与基因表达的影响[J].中医学报,2019,34(6):1253-1257.
[9] 黄红泓,覃日宏,柳贤福.中药当归的化学成分分析与药理作用探究[J].世界最新医学信息文摘,2019,19(58):127,153.
[10] 郑丽莉.芎归六君子汤对心肌梗死大鼠G-CSF含量和VEGF、bFGF表达的影响[J].中国老年学杂志,2019,39(9):2218-2221.
[11] 韩 炜.川芎的化学成分与药理作用研究进展[J].中国现代中药,2017,19(9):1341-1349.
[12] 鲁利甫,邱雪银,魏振国.当归四逆汤加减联合麝香保心丸治疗老年冠心病心绞痛疗效及对患者心电图、血清因子水平的影响[J].陕西中医,2019,40(5):587-590.
[13] 张燕丽,孟凡佳,田 园,等.炙甘草的化学成分与药理作用研究进展[J].化学工程师,2019,33(8):60-63,66.
[14] Enas EA,Varkey B,Dharmarajan TS,et al.Lipoprotein(a):Anindependent,genetic,and causal factor for cardiovascular disease and acutemyocardial infarction[J].Indian Heart J,2019,71(2):99-112.
[15] 刘耀武.四逆汤联合溶栓治疗急性心肌梗死缺血再灌注损伤及对患者动态心电图和SOD、CK-MB、LDH的影响[J].陕西中医,2019,40(7):858-860.
[16] Nowak RM,Christenson RH,Jacobsen G,et al.Performance of novel high-sensitivitycardiac troponin I assays for 0/1-hour and 0/2-to 3-hour evaluations for acutemyocardial infarction:Results from the HIGH-US study[J].Ann Emerg Med,2020,76(1):1-13.
[17] 李军涛,田荣英.心肌酶谱、肌钙蛋白、肌红蛋白与脑钠肽联合检测在早期急性心肌梗死诊断中的临床价值[J].河北医药,2019,41(12):1779-1783.
[18] Pu Q,Yang X,Guo Y,et al.Simultaneouscolorimetric determination of acute myocardial infarction biomarkers byintegrating self-assembled 3D gold nanovesicles into a multiple immunosorbentassay[J].Mikrochim Acta,2019,186(3):138.
[19] 刘 渊,崔 艳.冠心病患者血液检验相关指标临床观察[J].陕西医学杂志,2021,50(7):875-877,881.
[20] 陆 洋,颜永进,顾顺忠,等.急性心肌梗死及心力衰竭患者NT-proBNP、Myo和cTnT的水平变化及诊断价值[J].河北医药,2019,41(2):223-225,229.
相似文献/References:
[1]杨 敏,姜钧文,肖 蕾.中医体质与急性心肌梗死及其危险因素的相关性研究*[J].陕西中医,2019,(4):437.
YANG Min,JIANG Junwen,XIAO Lei..Study on the correlation between constitution of traditional Chinese medicine and acute myocardial infarction and its risk factors[J].,2019,(11):437.
[2]刘耀武.四逆汤联合溶栓治疗急性心肌梗死缺血再灌注损伤及对患者动态心电图和SOD、CK-MB、LDH的影响[J].陕西中医,2019,(7):858.
[3]范国萍,闫新慧.通络养心汤对急性心肌梗死经皮冠状动脉介入术后高缺血风险患者血小板抑制率及出血事件的影响*[J].陕西中医,2019,(8):1025.
FAN Guoping,YAN Xinhui..Effect of Tongluo Yangxin decoction in treating acute myocardial infarction combined with high risk of ischemia and evaluate the platelet inhibition rate and hemorrhage events risk[J].,2019,(11):1025.
[4]陈伟国,朱萧玲,常 盼,等.芪参益气滴丸对急性心肌梗死PCI术后患者血清学指标及预后的影响*[J].陕西中医,2020,(1):20.
CHEN Weiguo,ZHU Xiaoling,CHANG Pan,et al.Fects of Qishen Yiqi dropping refs on serum indexes and prognosis 〖JZ〗of patients with acute myocardial infarction after PCI[J].,2020,(11):20.
[5]宋金玉,杜 鑫,施继红,等.芪苈强心胶囊联合米力农对心肌梗死合并心力衰竭患者动脉血流和心功能的影响*[J].陕西中医,2020,(4):493.
[6]李倩宇,卢健棋,温志浩,等.基于PI3K/Akt通路探讨补阳还五汤对急性心肌梗死大鼠内皮祖细胞凋亡的影响[J].陕西中医,2023,(7):827.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.001]
LI Qianyu,LU Jianqi,WEN Zhihao,et al.Effect of Buyang Huanwu prescription on apoptosis of endothelial progenitor cells in rats with acute myocardial infarction based on PI3K/Akt pathway[J].,2023,(11):827.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.001]